SLU7 and Cockayne syndrome: We first investigated if splicing factor expression profiles were altered in dermal fibroblasts from donors with Hutchinson-Gilford Progeria syndrome, Werner syndrome and Cockayne syndrome, and secondly, if a known senomorphic drug, trametinib, could impact senescence kinetics and splicing factor expression in these cell populations.